Health & Fitness
Health and Fitness
Health and Fitness 
Thu, February 9, 2012
Orexigen Therapeutics to Present at Upcoming Conferences
Orexigen Therapeutics to Present at Upcoming Conferences -- SAN DIEGO, Feb. 9, 2012 /PRNewswire/ --
Orexigen Therapeutics to Present at Upcoming Conferences
SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: [ OREX ]) today announced that management will be presenting at two upcoming investor conferences. The details are as follows:
The 14th Annual BIO CEO & Investor Conference
Date: February 13, 2012
Time: 1:30pm Eastern Time
Location: Waldorf Astoria, New York
Speaker: Michael Narachi, President and Chief Executive Officer
Leerink Swann Global Healthcare Conference
Date: February 15, 2012
Time: 8:00am Eastern Time
Location: Waldorf Astoria, New York
Speaker: Michael Narachi, President and Chief Executive Officer
To listen to the live webcast or a replay of the presentations, please visit the Investor Relations section of the company's Web site at [ www.orexigen.com ]. A replay will be available for 14 days after the event.
About Orexigen Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Contrave® has completed Phase 3 clinical trials for which a New Drug Application has been submitted and reviewed by the FDA, and the FDA has agreed to a SPA for the Contrave outcomes trial. The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at [ www.orexigen.com ].
Corporate Contacts: Orexigen
Orexigen | Media |
Jay Hagan | Denise Powell |
Chief Business Officer | WCG |
(858) 875-8673 | (510) 703-9491 |
SOURCE Orexigen Therapeutics, Inc.
[ Back to top ] RELATED LINKS
[ http://www.orexigen.com ]